Patents by Inventor Siobhan Fogarty

Siobhan Fogarty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
    Patent number: 10668084
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Grant
    Filed: October 20, 2015
    Date of Patent: June 2, 2020
    Assignee: Acerus Biopharma Inc.
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul José Pierre Marie Maes
  • Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
    Patent number: 10111888
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: October 30, 2018
    Assignee: ACERUS BIOPHARMA INC.
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul José Pierre Marie Maes
  • Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
    Patent number: 9757388
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: September 12, 2017
    Assignee: Acerus Pharmaceuticals SRL
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • INTRANASAL 0.15% AND 0.24% TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20160271144
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: October 23, 2015
    Publication date: September 22, 2016
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul José Pierre Marie Maes
  • INTRANASAL 0.45% AND 0.48% TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20160250228
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: October 23, 2015
    Publication date: September 1, 2016
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul José Pierre Marie Maes
  • INTRANASAL LOWER DOSAGE STRENGTH TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20160175321
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: October 20, 2015
    Publication date: June 23, 2016
    Inventors: Wayne Carper, Siobhan Fogarty, Werner Oberegger, Paul José Pierre Marie Maes
  • INTRANASAL 0.6% AND 0.72% TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20130059827
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: May 14, 2012
    Publication date: March 7, 2013
    Applicant: Trimel Pharmaceuticals Corporation
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • INTRANASAL 0.15% AND 0.24% TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20130045958
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: May 14, 2012
    Publication date: February 21, 2013
    Applicant: Trimel Pharmaceuticals Corporation
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • INTRANASAL 0.45% AND 0.48% TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20130040922
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: May 14, 2012
    Publication date: February 14, 2013
    Applicant: Trimel Pharmaceuticals Corporation
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • INTRANASAL LOWER DOSAGE STRENGTH TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20130040923
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: May 14, 2012
    Publication date: February 14, 2013
    Applicant: Trimel Pharmaceuticals Corporation
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • Enalapril microspheres, dosage forms and chronotherapeutic methods based thereon
    Publication number: 20040137060
    Abstract: The invention provides coated particles containing: 1) monodispersed solid microspheres of Enalapril having a smooth spherical surface, and having a mean particle size of not greater than 500 microns prepared by a) subjecting a feedstock containing at least at least Enalapril as active ingredient and capable of being transformed to liquiform in the substantial absence of dissolving medium, to liquiflash conditions, which transform said feedstock from a solid to a liquid to a solid in less than five (5) seconds, said liquid characterized as having substantially unimpeded internal flow, and b) imparting shear force against flowing feedstock resulting from step “a)” in an amount sufficient to separate discrete particles by natural mass separation of said flowing feedstock in the presence of shear force impinging thereon while in said unimpeded-flow condition, wherein any active ingredient is substantially evenly distributed throughout the particles; and 2) at least one coating of a substance selected
    Type: Application
    Filed: May 13, 2003
    Publication date: July 15, 2004
    Inventors: Siobhan Fogarty, Paul Maes
  • Sedative non-benzodiazepine formulations
    Publication number: 20030165566
    Abstract: The invention provides for an enhanced absorption pharmaceutical composition comprising a plurality of microparticles, each microparticle comprising at least one sedative non-benzodiazepine, at least one spheronization aid and at least one solubility enhancer. The microparticles of the invention are further incorporated into an oral fast-dispersing dosage form.
    Type: Application
    Filed: January 9, 2003
    Publication date: September 4, 2003
    Inventors: Edel O'Toole, Siobhan Fogarty